Comments
Loading...

Camp4 Therapeutics

CAMPNASDAQ
Logo brought to you by Benzinga Data
$7.63
-1.25-14.08%
At close: -
$8.85
1.2215.99%
After Hours: 7:32 AM EDT
Consensus Rating1
Overweight
Highest Price Target1
$23.00
Lowest Price Target1
$0.30
Consensus Price Target1
$9.97

Camp4 Therapeutics (NASDAQ:CAMP) Stock, Analyst Ratings, Price Targets, Forecasts

Camp4 Therapeutics Corp has a consensus price target of $9.97 based on the ratings of 9 analysts. The high is $23 issued by JP Morgan on November 5, 2024. The low is $0.3 issued by Goldman Sachs on January 11, 2024. The 3 most-recent analyst ratings were released by Leerink Partners, JP Morgan, and Piper Sandler on November 5, 2024, respectively. With an average price target of $19.33 between Leerink Partners, JP Morgan, and Piper Sandler, there's an implied 118.46% upside for Camp4 Therapeutics Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
4
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Leerink Partners
JP Morgan
Piper Sandler
Goldman Sachs
Craig-Hallum

1calculated from analyst ratings

Analyst Ratings for Camp4 Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Camp4 Therapeutics (CAMP) stock?

A

The latest price target for Camp4 Therapeutics (NASDAQ:CAMP) was reported by William Blair on November 5, 2024. The analyst firm set a price target for $0.00 expecting CAMP to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Camp4 Therapeutics (CAMP)?

A

The latest analyst rating for Camp4 Therapeutics (NASDAQ:CAMP) was provided by William Blair, and Camp4 Therapeutics initiated their outperform rating.

Q

When was the last upgrade for Camp4 Therapeutics (CAMP)?

A

The last upgrade for Camp4 Therapeutics Corp happened on August 16, 2022 when Craig-Hallum raised their price target to $10. Craig-Hallum previously had a hold for Camp4 Therapeutics Corp.

Q

When was the last downgrade for Camp4 Therapeutics (CAMP)?

A

The last downgrade for Camp4 Therapeutics Corp happened on October 6, 2023 when Craig-Hallum changed their price target from N/A to $0.5 for Camp4 Therapeutics Corp.

Q

When is the next analyst rating going to be posted or updated for Camp4 Therapeutics (CAMP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Camp4 Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Camp4 Therapeutics was filed on November 5, 2024 so you should expect the next rating to be made available sometime around November 5, 2025.

Q

Is the Analyst Rating Camp4 Therapeutics (CAMP) correct?

A

While ratings are subjective and will change, the latest Camp4 Therapeutics (CAMP) rating was a initiated with a price target of $0.00 to $0.00. The current price Camp4 Therapeutics (CAMP) is trading at is $7.63, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch